Primary Site >> Pancreatic Cancer
Gene >> WT1
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
|
Ref: Localization of putative tumor suppressor loci by genome-wide allelotyping in human pancreatic endocrine tumors. PMID: 9721882 |
Ref: Desmoplastic small cell tumor in the pancreas. PMID: 15166674 Ref: Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma. PMID: 15245594 |
Ref: Gene expression profiles in primary pancreatic tumors and metastatic lesions of Ela-c-myc transgenic mice. PMID: 18218118 |
Ref: Wilms' tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cells. PMID: 19196508 |
Ref: Combination of MUC5ac and WT-1 immunohistochemistry is useful in distinguishing pancreatic ductal carcinoma from ovarian serous carcinoma in effusion cytology. PMID: 19856421 Ref: [WT1 peptide pulsed dendritic cell therapy with activated T lymphocytes therapy for advanced cancers]. PMID: 21224534 |
Ref: Gemcitabine enhances Wilms' tumor gene WT1 expression and sensitizes human pancreatic cancer cells with WT1-specific T-cell-mediated antitumor immune response. PMID: 21607557 |
Ref: [WT1-targeting cancer vaccine]. PMID: 23259381 |
Ref: Wilms tumor gene (WT1) peptide-based cancer vaccine combined with gemcitabine for patients with advanced pancreatic cancer. PMID: 24509173 Ref: [Efficacy of WT1 peptide-/MUC-1 peptide-pulsed dendritic cell therapy in 313 patients with a wide range of cancers]. PMID: 25335717 Ref: [Adjuvant therapy with WT1 peptide-pulsed dendritic cell therapy in combination with TS-1 for pancreatic cancer with positive peritoneal cytology after curative operation]. PMID: 25335723 Ref: Chemoimmunotherapy targeting Wilms' tumor 1 (WT1)-specific cytotoxic T lymphocyte and helper T cell responses for patients with pancreatic cancer. PMID: 25941581 |
Ref: Fine-needle aspiration diagnosis of high grade adenoid cystic carcinoma metastatic to the pancreas. PMID: 24554389 Ref: Phase I pilot study of Wilms tumor gene 1 peptide-pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancer. PMID: 25614082 |
Ref: Dendritic cell-based vaccine for pancreatic cancer in Japan. PMID: 26855819 Ref: [WT1 Class I Peptide/WT1 Class II Peptide Pulsed Dendritic Cell Therapy Efficacy in 60 Patients with a Wide Range of Advanced Cancers]. PMID: 27760951 |